Nippon Steel plans to raise up to $5.6 billion in subordinated loans, as part of efforts to strengthen its balance sheet following its $14 billion acquisition of U.S. Steel.

INmune Bio's XPro shows promise in early AD despite missed endpoints. Click here to find out why I rate INMB stock is a Hold.

Moody’s affirmation of Baa2 at C.H. Robinson holds its rating on the 3PL that has been in place since at least 2018. S&P ...

Earnings diversity and robust capital has led S&P to upgrade its long-term issuer and financial strength ratings on Arch’s ...

Discover JMBS, an active ETF focusing on agency mortgages with higher yields and returns. Compare its performance to bond ...